Clarify the Role of Ongentys and Kynmobi for Parkinson's Disease

Ongentys (opicapone) and Kynmobi (apomorphine) will add to the growing list of new meds for Parkinson's disease.

They're for "off" episodes...when symptoms (tremor, etc) return between carbidopa/levodopa doses, especially as Parkinson's progresses.

Recommend optimizing carbidopa/levodopa first...such as with more frequent dosing. Put the role of the new meds in perspective.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote